Insider Transactions in Q1 2024 at First Wave Bio Pharma, Inc. (FWBI)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Sarah Romano Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,120
-5.52%
|
$4,480
$4.96 P/Share
|
|
Mar 15
2024
|
James Sapirstein Chairman and CEO |
SELL
Open market or private sale
|
Direct |
1,887
-4.82%
|
$7,548
$4.96 P/Share
|
|
Mar 13
2024
|
Chaitan Phd Khosla Director |
BUY
Grant, award, or other acquisition
|
Indirect |
440
+50.0%
|
-
|
|
Mar 13
2024
|
Jack Syage President & COO |
BUY
Grant, award, or other acquisition
|
Indirect |
15,400
+50.0%
|
-
|
|
Jan 12
2024
|
James Sapirstein Chairman and CEO |
SELL
Open market or private sale
|
Direct |
166
-0.42%
|
$664
$4.2 P/Share
|
|
Jan 12
2024
|
Sarah Romano Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
98
-0.48%
|
$392
$4.2 P/Share
|
|
Jan 02
2024
|
Edward Borkowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,633
+49.23%
|
-
|
|
Jan 02
2024
|
Mary Theresa Coelho Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,633
+49.24%
|
-
|
|
Jan 02
2024
|
Alastair Riddell Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,633
+49.24%
|
-
|
|
Jan 02
2024
|
Charles J Casamento Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,633
+49.62%
|
-
|
|
Jan 02
2024
|
James Sapirstein Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+33.71%
|
-
|
|
Jan 02
2024
|
Sarah Romano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+25.54%
|
-
|